Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect Of Semaglutide In Coronary Atherosclerotic Plaqus Assessed by Coronay CT

NCT05071417 is registered in ClinicalTrials.gov with Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León as lead sponsor.

NCT NCT05071417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05071417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect Of Semaglutide In Coronary Atherosclerotic Plaqus Assessed by Coronay CT
Lead sponsor
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2021
Completion date
December 31, 2025
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atheroscleroses, coronary